Your browser doesn't support javascript.
loading
Nonpharmacologic Treatments for Opioid Reduction in Patients With Advanced Chronic Kidney Disease.
Brintz, Carrie E; Cheatle, Martin D; Dember, Laura M; Heapy, Alicia A; Jhamb, Manisha; Shallcross, Amanda J; Steel, Jennifer L; Kimmel, Paul L; Cukor, Daniel.
Afiliación
  • Brintz CE; Division of Pain Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN. Electronic address: carrie.brintz@vumc.org.
  • Cheatle MD; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Dember LM; Renal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Heapy AA; Pain Research Informatics Multimorbidities and Education Center of Innovation, Veterans' Affairs Connecticut Healthcare System, West Haven, CT; Department of Psychiatry, Yale School of Medicine, New Haven, CT.
  • Jhamb M; Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
  • Shallcross AJ; Department of Population Health, New York University School of Medicine, New York, NY.
  • Steel JL; Department of Surgery, University of Pittsburgh, Pittsburgh, PA; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA; Department of Psychology, University of Pittsburgh, Pittsburgh, PA; Behavioral Health, The Rogosin Institute, New York, NY.
  • Kimmel PL; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.
  • Cukor D; Behavioral Health, The Rogosin Institute, New York, NY.
Semin Nephrol ; 41(1): 68-81, 2021 01.
Article en En | MEDLINE | ID: mdl-33896475
ABSTRACT
Opioid analgesics carry risk for serious health-related harms in patients with advanced chronic kidney disease (CKD) and end-stage kidney disease. In the general population with chronic noncancer pain, there is some evidence that opioid reduction or discontinuation is associated with improved pain outcomes; however, tapering opioids abruptly or without providing supportive interventions can lead to physical and psychological harms and relapse of opioid use. There is emerging evidence that nonpharmacologic treatments such as psychosocial interventions, acupuncture, and interdisciplinary pain management programs are effective approaches to support opioid dose reduction in patients experiencing persistent pain, but research in this area still is relatively new. This review describes the current evidence for nonpharmacologic interventions to support opioid reduction in non-CKD patients with pain and discusses the application of the available evidence to patients with advanced CKD who are prescribed opioids to manage pain.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Dolor Crónico Límite: Humans Idioma: En Revista: Semin Nephrol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insuficiencia Renal Crónica / Dolor Crónico Límite: Humans Idioma: En Revista: Semin Nephrol Año: 2021 Tipo del documento: Article